Technology for vascular health
Detect cardiovascular diseases years in advance – when they are still preventable!
Microcirculation is life
More than 80% of cardiovascular diseases can be prevented if the risk factors are identified and eliminated in time.
But most people don’t know their own cardiovascular risk.
Cardiovascular diseases are the most common cause of death worldwide
The microcirculation is the functionally crucial endpoint of the cardiovascular system
Despite the importance of the microcirculation to human health, accurate noninvasive measurements have not been possible in the past.
We offer new perspectives for diagnostic care.
26% Macrocirculation
74% Microcirculation
Detect cardiovascular disease years in advance when it is still treatable!
Functional vascular changes can be detected using risk markers – long before the first morphological damage becomes apparent.
With our Retinal Vessel Analysis technology, we set the gold standard and are highly recognized in the scientific community.
Our product areas
Our algorithms for static vessel analysis allow a non-invasive and contact-free examination of the morphology of retinal vessels. This is associated with general vascular health and the global state of microcirculation and is therefore an integral part of modern cardiovascular diagnostics .
Our dynamic vessel analysis is a globally unique method for the non-invasive examination of the function and autoregulation of retinal vessels using video sequences. The vascular caliber along the vessels is recorded and analyzed in a time-variant manner on the retina .
With the RCrodent systems, Imedos offers the only commercially available solution for non-contact imaging and fluorescein angiography for the smallest eyes. We provide you with the tools for simple static and dynamic examination of the microcirculation , including on the animal model.
Ophthalmodynamometry
With the IOPstim system, Imedos is the only provider to offer a simple and painless increase in intraocular pressure for research as a prerequisite for the gentle measurement of retinal venous pressure for improved diagnosis of eye diseases such as glaucoma.
Cardiology
In addition to the important and efficient assessment of the cardiovascular risk of your patients, the methods of retinal vascular analysis are also suitable for various applications in clinical routine. For example, there is a discrepancy between standardized risk scores and the occurrence of coronary heart disease in women.
Ophthalmology
Impaired blood flow in the eye is often the cause of the occurrence or progression of many eye diseases. Imedos' technology makes it possible to diagnose these vascular components and then check the effect of a therapy.
Neurology
Pathologies of the microcirculation are associated with diverse clinical pictures in neurology. Therefore, the parameters of Retinal Vessel Analysis are suitable to draw conclusions about the risk of stroke, the severity of cerebral vascular diseases or other neurological diseases such as Alzheimer's disease.
Cardiometabolic prevention
The aim of cardiometabolic prevention is to prevent or delay the development and manifestation of vascular diseases at an early stage. The parameters of retinal vascular analysis offer new possibilities to extend the established gold standards of macrovascular diagnostics through microcirculation.
Nephrology
Recent studies have shown associations between changes in the retinal vessels, arterial hypertension and renal changes. An example of this are results showing the correlation between venous dysregulation and mortality in patients with end-stage chronic renal failure. In these studies, our dynamic vascular analysis represents a novel diagnostic tool for risk stratification.
Hypertensiology
Around 1.3 billion people worldwide suffer from hypertension. However, as this disease is usually asymptomatic in the beginning, a good half of these patients are unaware of their illness and the associated risk. The microvessels of the retina are very sensitive to changes in blood pressure and thus often provide the first clues to development or pre-existing disease.
Our users
News
Microcirculation in microgravity
Imedos is currently on another exciting mission: together with scientists from the University of Düsseldorf, we are once again investigating the behavior of the microvessels of th
Off to bed and keep your eyes peeled for space medicine
Imedos technology for retinal vessel analysis is part of the latest bed rest study of NASA and DLR. During space missions, astronauts regularly experience extreme situations that a
The eye tells more than a thousand words
Preventing strokes by looking in the eye? This sounds futuristic, and yet something similar is already possible today. Our retinal vessel analysis devices allow the examination of
Current study: Does the functional analysis of retinal vessels allow statements on the progression of COVID-19?
The University Hospital Jena (UKJ) and the Jena-based manufacturer of medical devices Imedos Systems GmbH have joint forces to determine whether the functional analysis of vessels
Retinal vessel analysis and obesity
Retinal Vessel Analysis and Obesity: static vessel analysis delivers innovative method to assess therapeutic success in obese patients Almost a quarter of all adults in Germany suf
Hypertension in childhood
Specialist article provides new insights: Development of high blood pressure can be detected as early as in childhood According to a new study from Switzerland using the method of
Targeted identification of high-risk individuals for severe progressions of COVID-19
Imedos Static Vessel Analysis: eye scan enables targeted identification of individuals at risk for severe COVID-19 progression Despite initial easing of lockdowns and restrictions
Imedos takes off: Vascular analysis in weightlessness
Astronauts and jet pilots regularly put themselves in extreme situations that can affect your health and trigger ailments. Das German Aerospace Center (DLR) is constant
Shooting date with MDR Thuringia
At the end of last year, we received an interesting inquiry from Mitteldeutscher Rundfunk (MDR): The editors were interested in our technology of retinal vessel analysis. They woul
